Image-guided Percutaneous Cryoablation of a Solitary Subpleural Lung Metastasis from Breast Cancer

Overview

Journal BMJ Case Rep

Specialty General Medicine

Date 2023 Oct 19

PMID 37857535

Authors

John Valtersson

Marianne Vogsen

Ole Graumann

Pia Iben Pietersen

Affiliations

Soon will be listed here.

Abstract

This case presents CT-guided percutaneous cryoablation as a treatment option in a patient with oligometastatic breast cancer who previously had received standard-of-care treatment for metastatic breast cancer. Before cryoablation, the patient received two systemic lines of therapy, several surgeries and radiotherapy for oligometastatic disease. The cryoablation was performed in a single 7 mm subpleural oligometastatic lesion 42 months after diagnosis of metastatic breast cancer. It was performed without complications, and the patient experienced no complaints or discomfort after the procedure. A 3-month, 6-month, 9-month and 12-month follow-up fluorodeoxyglucose-positron emission tomography/CT scans showed no sign of disease progression.

References

Niu L, Mu F, Zhang C, Li Y, Liu W, Jiang F . Cryotherapy protocols for metastatic breast cancer after failure of radical surgery. Cryobiology. 2013; 67(1):17-22. DOI: 10.1016/j.cryobiol.2013.04.004. View

Tafti B, Genshaft S, Suh R, Abtin F . Lung Ablation: Indications and Techniques. Semin Intervent Radiol. 2019; 36(3):163-175. PMC: 6699876. DOI: 10.1055/s-0039-1693981. View

Okunieff P, Petersen A, Philip A, Milano M, Katz A, Boros L . Stereotactic Body Radiation Therapy (SBRT) for lung metastases. Acta Oncol. 2006; 45(7):808-17. DOI: 10.1080/02841860600908954. View

Nielsen T, Vedel P, Borgbjerg J, Andersen G, Borre M . Renal cryoablation: five- and 10-year survival outcomes in patients with biopsy-proven renal cell carcinoma. Scand J Urol. 2020; 54(5):408-412. DOI: 10.1080/21681805.2020.1794954. View

Sharma A, Duijm M, Oomen-de Hoop E, Aerts J, Verhoef C, Hoogeman M . Survival and prognostic factors of pulmonary oligometastases treated with stereotactic body radiotherapy. Acta Oncol. 2018; 58(1):74-80. DOI: 10.1080/0284186X.2018.1521986. View

Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

Degn S, Davidsen J, Graumann O . Cryoablation: a potential treatment option for renal metastasis from lung cancer?. BMJ Case Rep. 2018; 2018. PMC: 6214398. DOI: 10.1136/bcr-2018-225841. View

Nesbit E, Donnelly E, Strauss J . Treatment Strategies for Oligometastatic Breast Cancer. Curr Treat Options Oncol. 2021; 22(10):94. DOI: 10.1007/s11864-021-00889-2. View

Junker T, Rasmussen B, Toft A, Graumann O . Percutaneous cryoablation of a solitary, soft-tissue metastasis from renal cell carcinoma: a new local minimal invasive curative treatment. BMJ Case Rep. 2019; 12(3). PMC: 6453360. DOI: 10.1136/bcr-2018-227129. View

10.

Aarts B, Klompenhouwer E, Rice S, Imani F, Baetens T, Bex A . Cryoablation and immunotherapy: an overview of evidence on its synergy. Insights Imaging. 2019; 10(1):53. PMC: 6527672. DOI: 10.1186/s13244-019-0727-5. View

11.

Waks A, Winer E . Breast Cancer Treatment: A Review. JAMA. 2019; 321(3):288-300. DOI: 10.1001/jama.2018.19323. View

12.

Stacul F, Sachs C, Giudici F, Bertolotto M, Rizzo M, Pavan N . Cryoablation of renal tumors: long-term follow-up from a multicenter experience. Abdom Radiol (NY). 2021; 46(9):4476-4488. PMC: 8346457. DOI: 10.1007/s00261-021-03082-z. View

13.

Han S, Choi J . Impact of 18F-FDG PET, PET/CT, and PET/MRI on Staging and Management as an Initial Staging Modality in Breast Cancer: A Systematic Review and Meta-analysis. Clin Nucl Med. 2021; 46(4):271-282. PMC: 7938917. DOI: 10.1097/RLU.0000000000003502. View

14.

Harbeck N, Penault-Llorca F, Cortes J, Gnant M, Houssami N, Poortmans P . Breast cancer. Nat Rev Dis Primers. 2019; 5(1):66. DOI: 10.1038/s41572-019-0111-2. View

15.

AlSendi M, OReilly D, Zeidan Y, Kelly C . Oligometastatic breast cancer: Are we there yet?. Int J Cancer. 2021; 149(8):1520-1528. DOI: 10.1002/ijc.33693. View

16.

Prudhomme C, Deschamps F, Moulin B, Hakime A, Al-Ahmar M, Moalla S . Image-guided lung metastasis ablation: a literature review. Int J Hyperthermia. 2019; 36(2):37-45. DOI: 10.1080/02656736.2019.1647358. View

17.

Mahnken A, Konig A, Figiel J . Current Technique and Application of Percutaneous Cryotherapy. Rofo. 2018; 190(9):836-846. DOI: 10.1055/a-0598-5134. View

18.

Hildebrandt M, Gerke O, Baun C, Falch K, Hansen J, Farahani Z . [18F]Fluorodeoxyglucose (FDG)-Positron Emission Tomography (PET)/Computed Tomography (CT) in Suspected Recurrent Breast Cancer: A Prospective Comparative Study of Dual-Time-Point FDG-PET/CT, Contrast-Enhanced CT, and Bone Scintigraphy. J Clin Oncol. 2016; 34(16):1889-97. DOI: 10.1200/JCO.2015.63.5185. View

19.

Inoue M, Nakatsuka S, Jinzaki M . Cryoablation of early-stage primary lung cancer. Biomed Res Int. 2014; 2014:521691. PMC: 4065703. DOI: 10.1155/2014/521691. View

20.

Ridouani F, Solomon S, Bryce Y, Bromberg J, Sofocleous C, Deipolyi A . Predictors of Progression-Free Survival and Local Tumor Control after Percutaneous Thermal Ablation of Oligometastatic Breast Cancer: Retrospective Study. J Vasc Interv Radiol. 2020; 31(8):1201-1209. DOI: 10.1016/j.jvir.2020.02.016. View